Muscle Relaxants and Barbiturates: Carisoprodol, Cyclobenzaprine, and Phenobarbital
A clinical reference on older sedatives, muscle relaxants, and barbiturates with significant abuse potential and dangerous withdrawal profiles.
Health & MedicineThe desk / continuation
Dispatches 385–395 of 476; page 33 of 40.
A clinical reference on older sedatives, muscle relaxants, and barbiturates with significant abuse potential and dangerous withdrawal profiles.
Health & MedicineAn exhaustive, legally accurate guide to India's drug classification system under the Drugs and Cosmetics Act and NDPS Act, covering Schedule H, H1, X, and the Narcotics Control Bureau.
Health & MedicineA comprehensive guide to Schedule H drugs under the Drugs and Cosmetics Rules 1945, covering what they are, why they need a prescription, and examples.
Health & MedicineA comprehensive guide to Schedule H1 drugs in India, including the complete list of controlled antibiotics, benzodiazepines, opioids, and anti-TB medications.
Health & MedicineA comprehensive guide to Schedule X drugs in India, the most heavily controlled pharmaceutical category reserved for narcotics and high-abuse substances.
Health & MedicineA comprehensive educational breakdown of the Narcotic Drugs and Psychotropic Substances Act, its punishment tiers, and enforcement by the NCB in India.
Health & MedicineAn educational analysis of the growing prescription drug abuse epidemic in India, covering the most commonly abused drug categories, statistics, and awareness resources.
Health & MedicineAn educational guide on the legal consequences of forging prescriptions using AI tools under the IPC/BNS, NDPS Act, and Drugs and Cosmetics Act in India.
Health & MedicineAn exhaustive, research-backed guide to Peer-to-Peer lending platforms in India covering RBI regulations, NPA rates, platform reviews, tax implications, and risk analysis.
Finance & InvestmentA comprehensive guide explaining the mechanics of Peer-to-Peer lending in India, how money flows through escrow accounts, and how lenders earn returns.
Finance & InvestmentA comprehensive guide to the RBI's regulatory framework for P2P lending in India, including the transformative August 2024 rule changes that banned guaranteed returns.
Finance & InvestmentAn in-depth review of India's major RBI-registered P2P lending platforms with real NPA data, fee structures, and investor experience analysis.
Finance & Investment